In Mayo Collaborative Services v. Prometheus Laboratories, Inc., decided March 20, 2012, the Supreme Court ruled unanimously that the claimed methods for optimizing the dosage of medication based on a body's reaction to the drug were unpatentable under section 101 of the Patent Act. In particular, the Court ruled that the patent claims covered “natural phenomena,” which cannot be patented because they are the fundamental building blocks of science.

Seminar Information
Seminar Date:
March 27, 2012
Supreme Court Finds That Patentable Subject Matter Does Not Extend to Diagnostic Methods Adding Only Well-Known Subject Matter to Natural Phenomena
Individual topic purchase: Selected
Online Materials
LES Member Price:$0.00
Non-Member Price:$0.00